Latest Capital Raise News

Terra Metals has secured an option to acquire a large tenement package adjacent to its flagship Dante Project, significantly expanding its exploration potential in Western Australia's West Musgrave region.

Nelson Resources bolstered its balance sheet with a $2.3 million placement and appointed Dr Louis Bucci as Executive Director, setting the stage for renewed exploration at its Fortnum and Yarri gold projects in early 2025.

Waratah Minerals Limited reported a $2.01 million net cash outflow from operating activities in the December 2024 quarter, ending with $4.23 million in cash and equivalents. The company continues its exploration efforts but faces notable cash burn that may pressure future funding.

Actinogen Medical accelerates recruitment in its pivotal XanaMIA Alzheimer's trial while securing a strong cash position of $22.9 million, underpinning its late-stage development and commercial readiness.

Agrimin Limited's latest quarterly cash flow report reveals a significant reduction in cash reserves alongside ongoing operational expenditures, prompting plans for further capital raising to maintain project momentum.

Syntara Limited has reported encouraging interim Phase 2 trial results for its lead drug candidate SNT-5505 in myelofibrosis, alongside a successful A$15 million capital raise to advance multiple clinical programs.

Metal Hawk Limited reports exceptional high-grade gold discoveries at its Leinster South Project, alongside a successful $2.5 million capital raise, setting the stage for imminent drilling activities.

DroneShield Limited reports a 6.3% increase in 2024 revenue to $57.5 million, underpinned by a doubling of SaaS sales and a robust $1.2 billion sales pipeline heading into 2025.

BOSS Energy Limited's December quarter cash flow report reveals a $7.9 million net cash outflow from operations and a slight reduction in cash reserves to $65.2 million, underscoring ongoing investment in exploration activities.

Imugene Limited has secured A$20 million through convertible notes as part of a broader A$46 million capital raise, aiming to advance its promising immuno-oncology pipeline.

Horizon Minerals reported a $5.165 million cash outflow for Q4 2024 but bolstered its liquidity with a capital raising in January 2025, extending its runway amid ongoing exploration investments.

Horizon Minerals reports a $14 million placement and a proposed merger with Poseidon Nickel, alongside key production milestones including the first gold pour at Boorara and a prefeasibility study at Penny's Find.